glp-1 mexico Hanmi Expands Obesity Drug Reach Through Deal π¨ New on cGxP.wire π¨ Hanmi expands the reach of its GLP-1 obesity drug through a licensing deal in Mexico, supporting broader access cardiology #diabetes #glp1 #cardiovascularhealth #mdac2026
Pay in 4 interest-free payments of $6.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 19 - Aug 24






















